
November 20th 2025
The Menopause Society Annual Meeting
Cochrane shares her own research findings on how clinician specialty shapes menopause care and highlights gaps in hormone therapy prescribing.

November 18th 2025
The Menopause Society Annual Meeting
TMS: Harvard's Caroline Mitchell, MD, MPH, questions the direction of genitourinary syndrome research priorities and reflects on FDA's removal of HRT warnings.

November 18th 2025
The Menopause Society Annual Meeting
Study author Daniel Jiang, MD, PhD, discusses data linking hormone therapy to increased autoimmune disease risk in postmenopausal women and clinical implications.

November 14th 2025
The Menopause Society Annual Meeting
Harvard's Caroline Mitchell, MD, MPH, explains how common OTC products can worsen vulvovaginal symptoms and the importance of a targeted history in GSM care.

November 14th 2025
The Menopause Society Annual Meeting
Donna Plecha, MD, discusses how AI-powered mammography risk prediction and polygenic risk scores will enable personalized breast cancer screening within the next decade.

November 14th 2025
The Menopause Society Annual Meeting
Breast imaging expert, Donna Plecha, MD, provides a roadmap for primary care physicians to implement risk assessment tools and high-risk clinic referrals in their practice.

November 13th 2025
The Menopause Society Annual Meeting
Access, cost, and clinician awareness remain significant barriers to implementing supplemental breast screening, according to Plecha.

November 12th 2025
The Menopause Society Annual Meeting
Breast imaging expert Donna M. Plecha, MD, explains the FDA's dense breast notification requirement and when to recommend supplemental MRI screening.

November 12th 2025
The Menopause Society Annual Meeting
Mitchell highlights hormone therapy prescribing for primary care: treatment algorithms, vaginal estrogen safety, and when progestins aren't needed.

November 11th 2025
The Menopause Society Annual Meeting
TMS 2025: Katrina Wugalter, MA, discusses research showing that age—not menopause stage—drives brain volume decline, and how lifestyle factors can help preserve brain health in midlife women.